Vitamin A and its biologically active derivatives, retinal and retinoic aci
d (RA), together with a large repertoire of synthetic analogues are collect
ively referred to as retinoids. Naturally occurring retinoids regulate the
growth and differentiation of a wide variety of cell types and play a cruci
al role in the physiology of vision and as morphogenic agents during embryo
nic development. Retinoids and their analogues have been evaluated as chemo
prevention agents, and also in the management of acute promyelocytic leukae
mia. Retinoids exert most of their effects by binding to specific receptors
and modulating gene expression. The development of new active retinoids an
d the identification of two distinct families of retinoid receptors has led
to an increased understanding of the cellular effects of activation of the
se receptors. In this article we review the use of retinoids in chemopreven
tion strategies, discuss the cellular consequences of activated retinoid re
ceptors, and speculate on how our increasing understanding of retinoid-indu
ced signalling pathways may contribute to future therapeutic strategies in
the management of malignant disease.